News

My husband recently received a $50,000 inheritance. We have no idea what to do with it. We want to be wise, but everything is ...
A new study sheds light on how behavioral symptoms are related to daily functioning in people with Alzheimer’s disease.
Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug. They ...
Neurogen Biomarking will present novel data on at-home p-tau 217 testing for Alzheimer’s disease at the upcoming Alzheimer’s Association International Conference® (AAIC) in Toronto, Canada. Chief ...
California is on the cusp of a demographic shift, with the number of people 65 and older skyrocketing by 59% over the next 15 ...
The Alzheimer's Association of Greater Kentucky and Southern Indiana held the kickoff party on Wednesday for its Walk to End ...
Illimis Therapeutics’ Series B round was led by Korean venture capital firm DSC Investment. Seoul-based Illimis Therapeutics ...
WHY do some people develop dementia, while others don’t? It’s a question that’s baffled scientists for decades. Some blame ...
Leqembi is the first FDA-approved drug shown to slow the progression of early-stage Alzheimer’s. Medi-Cal can cover Leqembi ...
Now, scientists say that eating just a couple of eggs a week could significantly reduce Alzheimer’s risk in older adults.
A free database of biomarker information on neurodegenerative diseases was released with backing from Bill Gates, Johnson & ...
Researchers now have a powerful new way to understand the types of brain cells that are affected in neurodegenerative diseases and to uncover connections between conditions such as Parkinson's, ...